Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis
- PMID: 36754993
- PMCID: PMC10600821
- DOI: 10.1017/S0033291723000144
Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis
Abstract
Background: Resting cerebral blood flow (rCBF) in striatum and thalamus is increased in medicated patients with psychosis, but whether this is caused by treatment or illness pathology is unclear. Specifically, effects of partial dopamine agonism, sex, and clinical correlates on rCBF are sparsely investigated. We therefore assessed rCBF in antipsychotic-naïve psychosis patients before and after aripiprazole monotherapy and related findings to sex and symptom improvement.
Methods: We assessed rCBF with the pseudo-Continuous Arterial Spin Labeling (PCASL) sequence in 49 first-episode patients (22.6 ± 5.2 years, 58% females) and 50 healthy controls (HCs) (22.3 ± 4.4 years, 63% females) at baseline and in 29 patients and 49 HCs after six weeks. RCBF in striatum and thalamus was estimated with a region-of-interest (ROI) approach. Psychopathology was assessed with the positive and negative syndrome scale.
Results: Baseline rCBF in striatum and thalamus was not altered in the combined patient group compared with HCs, but female patients had lower striatal rCBF compared with male patients (p = 0.009). Treatment with a partial dopamine agonist increased rCBF significantly in striatum (p = 0.006) in the whole patient group, but not significantly in thalamus. Baseline rCBF in nucleus accumbens was negatively associated with improvement in positive symptoms (p = 0.046), but baseline perfusion in whole striatum and thalamus was not related to treatment outcome.
Conclusions: The findings suggest that striatal perfusion is increased by partial dopamine agonism and decreased in female patients prior to first treatment. This underlines the importance of treatment effects and sex differences when investigating the neurobiology of psychosis.
Keywords: Antipsychotic treatment; antipsychotic-naïve; aripiprazole; cerebral blood flow; first-episode psychosis; first-episode schizophrenia; partial dopamine agonist; perfusion.
Conflict of interest statement
Drs KB Bojesen and K Tangmose received lecture fees from Lundbeck Pharma A/S.
Dr Glenthøj has been the leader of a Lundbeck Foundation Centre of Excellence for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS) (January 2009 – December 2021), which was partially financed by an independent grant from the Lundbeck Foundation based on international review and partially financed by the Mental Health Services in the Capital Region of Denmark, the University of Copenhagen, and other foundations. All grants are the property of the Mental Health Services in the Capital Region of Denmark and administrated by them. She has no other conflicts to disclose.
Dr BH. Ebdrup received lecture fees and/or is part of the advisory board at Bristol-Myers Squibb, Eli Lilly and Company, Janssen-Cilag, Otsuka Pharma Scandinavia AB, Takeda Pharmaceutical Company, Boehringer Ingelheim, and Lundbeck Pharma A/S.
The rest of the authors have no conflicts of interest to disclose.
Figures
References
-
- Alisch, J. S. R., Khattar, N., Kim, R. W., Cortina, L. E., Rejimon, A. C., Qian, W., … Bouhrara, M. (2021). Sex and age-related differences in cerebral blood flow investigated using pseudo-continuous arterial spin labeling magnetic resonance imaging. Aging (Albany NY), 13(4), 4911–4925. doi: 10.18632/aging.202673 - DOI - PMC - PubMed
-
- Allen, P., Azis, M., Modinos, G., Bossong, M. G., Bonoldi, I., Samson, C., … McGuire, P. (2018). Increased resting hippocampal and basal ganglia perfusion in people at ultra high risk for psychosis: Replication in a second cohort. Schizophrenia Bulletin, 44(6), 1323–1331. doi: 10.1093/schbul/sbx169 - DOI - PMC - PubMed
-
- Allen, P., Chaddock, C. A., Egerton, A., Howes, O. D., Bonoldi, I., Zelaya, F., … McGuire, P. (2016). Resting hyperperfusion of the hippocampus, midbrain, and basal ganglia in people at high risk for psychosis. American Journal of Psychiatry, 173(4), 392–399. doi: 10.1176/appi.ajp.2015.15040485 - DOI - PubMed
-
- Alsop, D. C., Detre, J. A., Golay, X., Gunther, M., Hendrikse, J., Hernandez-Garcia, L., … Zaharchuk, G. (2015). Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magnetic Resonance in Medicine, 73(1), 102–116. doi: 10.1002/mrm.25197 - DOI - PMC - PubMed
-
- Andersen, H. G., Raghava, J. M., Svarer, C., Wulff, S., Johansen, L. B., Antonsen, P. K., … Ebdrup, B. H. (2020). Striatal volume increase after six weeks of selective dopamine D2/3 receptor blockade in first-episode, antipsychotic-naive schizophrenia patients. Frontiers in Neuroscience, 14, 484. doi: 10.3389/fnins.2020.00484 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
